Moreover, a CXCR2 inhibiting peptide, ‘pepducin’, protects wild‐type mice against acute and chronic pancreatitis and, significantly, can reverse established pancreatic inflammation. This evidence concerns the gene CXCR2 and chronic pancreatitis.